LEO 22811 - A Single Dose Bioavailability Study of Oral Solid Dosage Form Versus Oral Solution Including Fed Versus Fasted State in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 28 Oct 2015
At a glance
- Drugs LEO 22811 (Primary)
- Indications Psoriasis
- Focus Pharmacokinetics
- 04 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 04 Feb 2011 Actual end date (December 2010) added as reported by ClinicalTrials.gov.
- 08 Oct 2010 New trial record